You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. In Situ Evaluation of 3-D Woven Composite Structural Performance Using Fiber Optic Sensors

    SBC: 3TEX, Inc.            Topic: N/A

    "Three-dimensional textile reinforcement architectures with straight in-plane fibers and optimized through thickness fiber content are considered as efficient solutions for the next generation of light weight, damage tolerant, high strength compositesallowing for cost-effective manufacturing solutions. The 3-D weaving process is gentle to the fibers, thus making automated fiber optic sensor insert ...

    STTR Phase II 2002 Department of DefenseAir Force
  2. 3-D Orthogonal Woven Composites in Armor Systems

    SBC: 3TEX, Inc.            Topic: N/A

    "3TEX, Inc., the Center for Composite Materials at the University of Delaware, and the University of Rhode Island propose to further develop 3-D orthogonal woven composite materials for armor applications. We will use a combined approach of new materialsdevelopment, instrumented high strain rate and ballistic testing, and numerical impact simulation, to further phase 1 results on S-2 glass structu ...

    STTR Phase I 2002 Department of DefenseArmy
  3. 3-D Orthogonal Woven Composites in Armor Systems

    SBC: 3TEX, Inc.            Topic: N/A

    "3TEX, Inc., the Center for Composite Materials at the University of Delaware, and the University of Rhode Island propose to further develop 3-D orthogonal woven composite materials for armor applications. We will use a combined approach of new materialsdevelopment, instrumented high strain rate and ballistic testing, and numerical impact simulation, to further phase 1 results on S-2 glass structu ...

    STTR Phase II 2002 Department of DefenseArmy
  4. Identification of the Species Responsible for Biological Inactivation in the OAUGDP

    SBC: Atmospheric Glow Technologies            Topic: N/A

    "Atmospheric Glow Technologies (AGT) proposes to initiate studies to elucidate the mechanism of inactivation of microorganisms using atmospheric plasma. In this Phase I work effort, AGT will identify and quantify the active species generated by the APD-210(Atmospheric Plasma Decon-210). The APD-210 has been independently shown to inactivate a number of different microorganisms including anthrax ...

    STTR Phase I 2002 Department of DefenseAir Force
  5. DEVELOPMENT OF A NEW TREATMENT OF URINARY STONE DISEASE

    SBC: BIOSTRATUM, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Development of a new method for prophylaxis and treatment of urinary stone disease is proposed. Since a majority of urinary stones are made of calcium oxalate, the level of urinary oxalate is one of the major risk factors of stone formation. Unfortunately, there is no effective pharmacological treatment of stone disease that targets urinary oxalate concentratio ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  6. ANAEROBIC MOBILIZATION TECHNOLOGY FOR SOIL REMEDIATION

    SBC: CHATHAM RESEARCH, LTD            Topic: N/A

    DESCRIPTION (provided by applicant): A major contamination issue at over 8,000 sites in the United States are PAHs. This contamination results from almost all combustion processes, creosote treatment of wood, former town gas sites, and many others. Many of these chemicals are both toxic and carcinogenic. It has been observed that these highly hydrophobic chemicals bind tightly to soil by a numb ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  7. Nanophotonic Modulator using Electromagnetically Induced Transparency

    SBC: Chronochrome, Inc.            Topic: N/A

    "The proposed high bandwidth electro-optic modulator uses an optical waveguide microcavity to enhance the interaction of optical fields with a material that exhibits coherent quantum attributes. The nonlinear characteristic of the light - matter coupling inconcert with the resonance requirements of the microcavity provide a sensitive modulation mechanism. In the device the combination of nanophoto ...

    STTR Phase I 2002 Department of DefenseAir Force
  8. A NOVEL DRUG FOR ASTHMA WITH DUAL ACTION VIA AL ARS

    SBC: ENDACEA, INC            Topic: N/A

    The incidence of asthma has more thandoubled from 6.7 million in 1980 to 17.3 million in 1998 in the U.S., including 4.3 million children. Current therapies for asthma have serious side effects. Airway adenosine levels are increased in patients with asthma. Activation of A1 adenosine receptors produces bronchoconstriction, airway edema, and acute inflammation, leading to airflow obstruction. Endac ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  9. P20, MOLECULAR SHORTSTOP FOR INFLAMMATORY LUNG DISEASES

    SBC: Generx+, Inc.            Topic: N/A

    The transcription factor CAAT enhancer binding protein beta (C/EBPbeta) is a key factor orchestrating the inflammatory response. Specifically, expression of the genes encoding the pro-inflammatory cytokines IL-6 and on IL-8 are regulated by C/EBPbeta. C/EBPbeta can be either an activator or an inhibitor of inflammation depending on the dominant isoforms produced. Our data indicate that airway epit ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  10. P20, MOLECULAR SHORTSTOP FOR INFLAMMATORY LUNG DISEASES

    SBC: Generx+, Inc.            Topic: N/A

    The transcription factor CAAT enhancer binding protein beta (C/EBPbeta) is a key factor orchestrating the inflammatory response. Specifically, expression of the genes encoding the pro-inflammatory cytokines IL-6 and on IL-8 are regulated by C/EBPbeta. C/EBPbeta can be either an activator or an inhibitor of inflammation depending on the dominant isoforms produced. Our data indicate that airway epit ...

    STTR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government